EMA recommends Covid-19 vaccination for children as young as 5
The European Medicines Agency's (EMA) special committee, the CHMP, has recommended the Pfizer-Biontech vaccine for children between the ages of 5 and 11.
by ritzau, translated by daniel pedersen
On Thursday, the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommends the approval of Covid-19 developed by Pfizer and Biontech for use in children aged 5 to 11 years.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
CHMP approves 11 new drugs, rejects one
For subscribers
EMA allows emergency use of MSD's Covid-19 capsule treatment
For subscribers
European pharma strategy report approved with huge majority
For subscribers
